[Carcinoembryonic antigen (CEA), serum amylase and pancreozymin-secretin test in relation to stages of pancreatic cancer].
In cases of surgically proved pancreatic carcinoma, preoperative values of serum CEA, serum amylase and pancreozymin-secretin test (PST) were seen if they related to the macroscopic stages of the tumor determined by "General Rules for Surgical and Pathological Studies on Cancer of Pancreas" offered by Japanese Pancreatic Society in April 1982. Serum CEA was determined in 43 cases, serum amylase in 34 cases and PST was done in 28 cases. All of CEA, amylase and PST showed no statistically significant relationship to the stages of the carcinoma. This may suggest that these tests may not be a useful indicator of the stage of tumor.
D000681:Amylases / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D002766:Cholecystokinin; D006801:Humans; D009367:Neoplasm Staging; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000201:enzymology / Q000276:immunology / Q000473:pathology; D012633:Secretin
D002272:Carcinoembryonic Antigen; D012633:Secretin; D002766:Cholecystokinin; D000681:Amylases